These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2543336)

  • 1. An attempt to reduce the photosensitizing potential of chlorpromazine with the simultaneous use of beta- and dimethyl-beta-cyclodextrins in guinea pigs.
    Hoshino T; Ishida K; Irie T; Uekama K; Ono T
    Arch Dermatol Res; 1989; 281(1):60-5. PubMed ID: 2543336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against the photosensitized skin irritancy of chlorpromazine by cyclodextrin complexation.
    Irie T; Uekama K
    J Pharmacobiodyn; 1985 Sep; 8(9):788-91. PubMed ID: 4087139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cyclodextrins on chlorpromazine-induced haemolysis and central nervous system responses.
    Uekama K; Irie T; Sunada M; Otagiri M; Iwasaki K; Okano Y; Miyata T; Kasé Y
    J Pharm Pharmacol; 1981 Nov; 33(11):707-10. PubMed ID: 6118408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction in the local tissue toxicity of chlorpromazine by beta-cyclodextrin complexation.
    Irie T; Kuwahara S; Otagiri M; Uekama K; Iwamasa T
    J Pharmacobiodyn; 1983 Oct; 6(10):790-2. PubMed ID: 6663444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solubility and mass and nuclear magnetic resonance spectroscopic studies on interaction of cyclosporin A with dimethyl-alpha- and -beta-cyclodextrins in aqueous solution.
    Miyake K; Hirayama F; Uekama K
    J Pharm Sci; 1999 Jan; 88(1):39-45. PubMed ID: 9874700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of the interaction of clobazam with cyclodextrins in solution and in the solid state.
    Nakai Y; el-Said Aboutaleb A; Yamamoto K; Saleh SI; Ahmed MO
    Chem Pharm Bull (Tokyo); 1990 Mar; 38(3):728-32. PubMed ID: 2347015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of PI3K-Akt-Bad pathway in apoptosis induced by 2,6-di-O-methyl-beta-cyclodextrin, not 2,6-di-O-methyl-alpha-cyclodextrin, through cholesterol depletion from lipid rafts on plasma membranes in cells.
    Motoyama K; Kameyama K; Onodera R; Araki N; Hirayama F; Uekama K; Arima H
    Eur J Pharm Sci; 2009 Oct; 38(3):249-61. PubMed ID: 19664706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stabilizing and solubilizing effects of sulfobutyl ether beta-cyclodextrin on prostaglandin E1 analogue.
    Uekama K; Hieda Y; Hirayama F; Arima H; Sudoh M; Yagi A; Terashima H
    Pharm Res; 2001 Nov; 18(11):1578-85. PubMed ID: 11758766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative studies of the enhancing effects of cyclodextrins on the solubility and oral bioavailability of tacrolimus in rats.
    Arima H; Yunomae K; Miyake K; Irie T; Hirayama F; Uekama K
    J Pharm Sci; 2001 Jun; 90(6):690-701. PubMed ID: 11357172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release characteristics of endogenous constituents by exposure of small intestine to modified beta-cyclodextrins.
    Tanino T; Ogiso T; Iwaki M; Yamaguchi T; Kakehi K
    Biol Pharm Bull; 1999 Oct; 22(10):1099-105. PubMed ID: 10549863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced rectal absorption and reduced local irritation of the anti-inflammatory drug ethyl 4-biphenylylacetate in rats by complexation with water-soluble beta-cyclodextrin derivatives and formulation as oleaginous suppository.
    Arima H; Kondo T; Irie T; Uekama K
    J Pharm Sci; 1992 Nov; 81(11):1119-25. PubMed ID: 1447717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heptakis(2,6-di-O-methyl-3-O-acetyl)-beta-cyclodextrin: A water-soluble cyclodextrin derivative with low hemolytic activity.
    Hirayama F; Mieda S; Miyamoto Y; Arima H; Uekama K
    J Pharm Sci; 1999 Oct; 88(10):970-5. PubMed ID: 10514341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inclusion complex of 3,9-bis(N,N-dimethylcarbamoyloxy)-5H-benzofuro[3,2-c]quinoline-6-one (KCA-098) with heptakis(2,6-di-O-methyl)-beta-cyclodextrin: interaction and dissolution properties.
    Yamada T; Imai T; Ouchi K; Otagiri M; Hirayama F; Uekama K
    Chem Pharm Bull (Tokyo); 2000 Sep; 48(9):1264-9. PubMed ID: 10993223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of 2-hydroxypropyl-beta-cyclodextrin in an intramuscular injectable preparation of nimodipine.
    Yoshida A; Yamamoto M; Itoh T; Irie T; Hirayama F; Uekama K
    Chem Pharm Bull (Tokyo); 1990 Jan; 38(1):176-9. PubMed ID: 2337940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of heptakis(2,6-di-O-ethyl)-beta-cyclodextrin and its nuclear magnetic resonance spectroscopic characterization.
    Hirayama F; Kurihara M; Horiuchi Y; Utsuki T; Uekama K; Yamasaki M
    Pharm Res; 1993 Feb; 10(2):208-13. PubMed ID: 8384365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of cyclodextrins on drug-induced hemolysis in vitro.
    Uekama K; Irie T; Sunada M; Otagiri M; Tsubaki K
    J Pharmacobiodyn; 1981 Feb; 4(2):142-4. PubMed ID: 7277200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to avoid phototoxic reactions in photopatch testing with chlorpromazine.
    Schauder S
    Photodermatol; 1985 Apr; 2(2):95-100. PubMed ID: 4034422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of novel hydrophilic cyclodextrin derivatives on nitric oxide production in macrophages stimulated with lipopolysaccharide.
    Arima H; Nishimoto Y; Motoyama K; Hirayama F; Uekama K
    Pharm Res; 2001 Aug; 18(8):1167-73. PubMed ID: 11587489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epimerization and racemization of some chiral drugs in the presence of cyclodextrin and liposomes.
    Aso Y; Yoshioka S; Takeda Y
    Chem Pharm Bull (Tokyo); 1989 Oct; 37(10):2786-9. PubMed ID: 2611938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some pharmaceutical properties of 3-hydroxypropyl- and 2,3-dihydroxypropyl-beta-cyclodextrins and their solubilizing and stabilizing abilities.
    Yoshida A; Yamamoto M; Irie T; Hirayama F; Uekama K
    Chem Pharm Bull (Tokyo); 1989 Apr; 37(4):1059-63. PubMed ID: 2766408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.